India, Feb. 1 -- The Government of India issued the following news release:
Researchers have developed an innovative "self-actuating" drug delivery system that could revolutionize the treatment of rheumatoid arthritis (RA) by targeting inflammation directly within the joints so that therapeutic agents are released only when needed.
Rheumatoid arthritis (RA) affects millions of people worldwide, causing chronic inflammation, debilitating pain, and irreversible joint damage. Traditional treatments often rely on systemic drug administration, which not only carries the risk of significant side effects but also requires frequent dosing due to the rapid clearance of drugs from inflamed joints and is a challenge for long-lasting, localized relie...